CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,458 | -2.6% | 392,307 | +2.9% | 0.00% | – |
| Q2 2023 | $560,290 | -17.9% | 381,150 | -7.8% | 0.00% | – |
| Q1 2023 | $682,278 | +117941.2% | 413,502 | 0.0% | 0.00% | – |
| Q4 2022 | $578 | -99.9% | 413,502 | -0.2% | 0.00% | – |
| Q3 2022 | $638,000 | -29.6% | 414,372 | +0.5% | 0.00% | – |
| Q2 2022 | $906,000 | -45.5% | 412,110 | -38.5% | 0.00% | – |
| Q1 2022 | $1,661,000 | -57.1% | 669,829 | +3.8% | 0.00% | – |
| Q4 2021 | $3,876,000 | -0.0% | 645,084 | +10.8% | 0.00% | -100.0% |
| Q3 2021 | $3,877,000 | +13.2% | 582,157 | +13.0% | 0.00% | – |
| Q2 2021 | $3,424,000 | +77.4% | 514,981 | +147.0% | 0.00% | – |
| Q1 2021 | $1,930,000 | -47.1% | 208,455 | +2.7% | 0.00% | -100.0% |
| Q4 2020 | $3,649,000 | +141.3% | 202,886 | +90.4% | 0.00% | – |
| Q3 2020 | $1,512,000 | +652.2% | 106,559 | +164.6% | 0.00% | – |
| Q2 2020 | $201,000 | – | 40,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |